Using advanced imaging to improve diagnosis and treatment prediction in multiple myeloma
AI-assisted quantitative photon-counting-detector CT imaging for cytogenetic risk prediction and treatment response in multiple myeloma
This study is exploring a new type of imaging technology to help doctors better understand and predict how multiple myeloma will respond to treatment, so patients can receive more accurate care tailored to their specific needs.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-11104309 on NIH RePORTER |
What this research studies
This research focuses on enhancing the diagnosis and treatment response prediction for multiple myeloma using a new imaging technology called photon-counting detector CT. Traditional bone marrow biopsies often fail to capture the full complexity of the disease, leading to inaccurate risk assessments. By employing advanced imaging techniques, the study aims to create models that can better stratify patients based on their cytogenetic risk. This approach could provide a more comprehensive understanding of the disease and improve treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with multiple myeloma who require cytogenetic assessment for risk stratification.
Not a fit: Patients who do not have a diagnosis of multiple myeloma or those who are not undergoing treatment for the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate risk assessments and personalized treatment plans for patients with multiple myeloma.
How similar studies have performed: Other research has shown promise in using advanced imaging techniques for cancer diagnosis and treatment monitoring, suggesting that this approach could be effective.
Where this research is happening
Rochester, United States
- Mayo Clinic Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Baffour, Francis — Mayo Clinic Rochester
- Study coordinator: Baffour, Francis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.